Cargando…

Ikaros controls isotype selection during immunoglobulin class switch recombination

Class switch recombination (CSR) allows the humoral immune response to exploit different effector pathways through specific secondary antibody isotypes. However, the molecular mechanisms and factors that control immunoglobulin (Ig) isotype choice for CSR are unclear. We report that deficiency for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sellars, MacLean, Reina-San-Martin, Bernardo, Kastner, Philippe, Chan, Susan
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715033/
https://www.ncbi.nlm.nih.gov/pubmed/19414557
http://dx.doi.org/10.1084/jem.20082311
_version_ 1782169725357260800
author Sellars, MacLean
Reina-San-Martin, Bernardo
Kastner, Philippe
Chan, Susan
author_facet Sellars, MacLean
Reina-San-Martin, Bernardo
Kastner, Philippe
Chan, Susan
author_sort Sellars, MacLean
collection PubMed
description Class switch recombination (CSR) allows the humoral immune response to exploit different effector pathways through specific secondary antibody isotypes. However, the molecular mechanisms and factors that control immunoglobulin (Ig) isotype choice for CSR are unclear. We report that deficiency for the Ikaros transcription factor results in increased and ectopic CSR to IgG(2b) and IgG(2a), and reduced CSR to all other isotypes, regardless of stimulation. Ikaros suppresses active chromatin marks, transcription, and activation-induced cytidine deaminase (AID) accessibility at the γ2b and γ2a genes to inhibit class switching to these isotypes. Further, Ikaros directly regulates isotype gene transcription as it directly binds the Igh 3′ enhancer and interacts with isotype gene promoters. Finally, Ikaros-mediated repression of γ2b and γ2a transcription promotes switching to other isotype genes by allowing them to compete for AID-mediated recombination at the single-cell level. Thus, our results reveal transcriptional competition between constant region genes in individual cells to be a critical and general mechanism for isotype specification during CSR. We show that Ikaros is a master regulator of this competition.
format Text
id pubmed-2715033
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-27150332009-11-11 Ikaros controls isotype selection during immunoglobulin class switch recombination Sellars, MacLean Reina-San-Martin, Bernardo Kastner, Philippe Chan, Susan J Exp Med Article Class switch recombination (CSR) allows the humoral immune response to exploit different effector pathways through specific secondary antibody isotypes. However, the molecular mechanisms and factors that control immunoglobulin (Ig) isotype choice for CSR are unclear. We report that deficiency for the Ikaros transcription factor results in increased and ectopic CSR to IgG(2b) and IgG(2a), and reduced CSR to all other isotypes, regardless of stimulation. Ikaros suppresses active chromatin marks, transcription, and activation-induced cytidine deaminase (AID) accessibility at the γ2b and γ2a genes to inhibit class switching to these isotypes. Further, Ikaros directly regulates isotype gene transcription as it directly binds the Igh 3′ enhancer and interacts with isotype gene promoters. Finally, Ikaros-mediated repression of γ2b and γ2a transcription promotes switching to other isotype genes by allowing them to compete for AID-mediated recombination at the single-cell level. Thus, our results reveal transcriptional competition between constant region genes in individual cells to be a critical and general mechanism for isotype specification during CSR. We show that Ikaros is a master regulator of this competition. The Rockefeller University Press 2009-05-11 /pmc/articles/PMC2715033/ /pubmed/19414557 http://dx.doi.org/10.1084/jem.20082311 Text en © 2009 Sellars et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
spellingShingle Article
Sellars, MacLean
Reina-San-Martin, Bernardo
Kastner, Philippe
Chan, Susan
Ikaros controls isotype selection during immunoglobulin class switch recombination
title Ikaros controls isotype selection during immunoglobulin class switch recombination
title_full Ikaros controls isotype selection during immunoglobulin class switch recombination
title_fullStr Ikaros controls isotype selection during immunoglobulin class switch recombination
title_full_unstemmed Ikaros controls isotype selection during immunoglobulin class switch recombination
title_short Ikaros controls isotype selection during immunoglobulin class switch recombination
title_sort ikaros controls isotype selection during immunoglobulin class switch recombination
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715033/
https://www.ncbi.nlm.nih.gov/pubmed/19414557
http://dx.doi.org/10.1084/jem.20082311
work_keys_str_mv AT sellarsmaclean ikaroscontrolsisotypeselectionduringimmunoglobulinclassswitchrecombination
AT reinasanmartinbernardo ikaroscontrolsisotypeselectionduringimmunoglobulinclassswitchrecombination
AT kastnerphilippe ikaroscontrolsisotypeselectionduringimmunoglobulinclassswitchrecombination
AT chansusan ikaroscontrolsisotypeselectionduringimmunoglobulinclassswitchrecombination